T023 (0106) SAFETY AND EARLY RESPONSE TO THE FIRST 2 CYCLES OF BRENTUXIMAB VEDOTIN SUBSTITUTING VINCRISTINE IN THE OEPA/COPDAC REGIMEN FOR HIGH RISK PEDIATRIC HODGKIN LYMPHOMA (HL)
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
Wiley
2018-10-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000547935.17200.58 |